Did anyone notice the lack of refererence to Covid? Is our submission to OTAT sufficient to proceed with the next trial? Will the next announcement be approval of that trial design?
Note that 12 month survival data should be coming soon.
Ann: Appendix 4C Quarterly Activity Report, page-82
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
0.000(0.00%) |
Mkt cap ! $1.598B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.42 | $1.38 | $1.562M | 1.118M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4928 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 27814 | 9 |
View Market Depth
| Last trade - 11.34am 10/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |